The result shows that in the high R3HDM1 expression group of almost all cancer types, cell proliferation-related signaling pathways (including MYC, mTORC1, spindle, G2M, and E2F pathways) are significantly enriched (Figure 5A). This evidence concerns the gene MYC and cancer.